Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
Journal Article
|Research
2020-02-25 • BMC Medicine
2020-02-25 • BMC Medicine
BACKGROUND
The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquin...
The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquin...
Protocol
|Research Protocol
2018-07-01
2018-07-01
Primary Objective: To measure the prevalence of molecular markers of SP resistant malaria in North and South Kivu, DRC.
Sulfadoxine/pyrimethamine (SP) forms the backbone of mos...
Sulfadoxine/pyrimethamine (SP) forms the backbone of mos...
Journal Article
|Research
2019-12-18 • Malaria Journal
2019-12-18 • Malaria Journal
BACKGROUND
Sulfadoxine–pyrimethamine (SP) is a cornerstone of malaria chemoprophylaxis and is considered for programmes in the Democratic Republic of Congo (DRC). However, SP efficac...
Sulfadoxine–pyrimethamine (SP) is a cornerstone of malaria chemoprophylaxis and is considered for programmes in the Democratic Republic of Congo (DRC). However, SP efficac...
Journal Article
|Letter
2020-08-07 • Nature Medicine
2020-08-07 • Nature Medicine
The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and deaths associated with COVID-19 are rising. In response, countries are implementing societal mea...